Valentina Brillo
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin/cholecystokinin B receptor ligand strongly reduces pancreatic ductal adenocarcinoma in orthotopic models.
Journal: Pharmacological research
Published: August 31, 2025
Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin/cholecystokinin B receptor ligand strongly reduces pancreatic ductal adenocarcinoma in orthotopic models.
Journal: Pharmacological research
Published: August 31, 2025
The Role of Transglutaminase 2 in Cancer: An Update.
Journal: International journal of molecular sciences
Published: January 22, 2024
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma.
Journal: Cell death & disease
Published: July 12, 2023
Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 20, 2023
Promising prognostic value of Transglutaminase type 2 and its correlation with tumor-infiltrating immune cells in skin cutaneous melanoma.
Journal: Cell death discovery
Published: April 20, 2022
Mitochondrial Dynamics, ROS, and Cell Signaling: A Blended Overview.
Journal: Life (Basel, Switzerland)
Published: March 02, 2021
From Channels to Canonical Wnt Signaling: A Pathological Perspective.
Journal: International journal of molecular sciences
Published: March 02, 2021
Mitochondrial dysfunction interferes with neural crest specification through the FoxD3 transcription factor.
Journal: Pharmacological research
Published: June 03, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026